|
|
Volumn 24, Issue 1, 2004, Pages 56-57
|
|
Angiotensin II receptor antagonist in pregnancy (multiple letters)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
CANDESARTAN;
LOSARTAN;
TELMISARTAN;
VALSARTAN;
DRUG CONTRAINDICATION;
DRUG MECHANISM;
FETUS DEVELOPMENT;
FETUS DISEASE;
FETUS OUTCOME;
FETUS RISK;
GESTATION PERIOD;
HUMAN;
HYPOTENSION;
ISCHEMIA;
LETTER;
MATERNAL DISEASE;
NEPHROTOXICITY;
NONHUMAN;
ORGANOGENESIS;
PLACENTA CIRCULATION;
PRENATAL DRUG EXPOSURE;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
RISK ASSESSMENT;
SECOND TRIMESTER PREGNANCY;
TERATOGENESIS;
THIRD TRIMESTER PREGNANCY;
WELLBEING;
ADULT;
ANTIHYPERTENSIVE AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
EMBRYONIC AND FETAL DEVELOPMENT;
FEMALE;
FOLLOW-UP STUDIES;
GESTATIONAL AGE;
HUMANS;
MATERNAL AGE;
PREGNANCY;
PREGNANCY OUTCOME;
PREGNANCY, HIGH-RISK;
RECEPTORS, ANGIOTENSIN;
RISK ASSESSMENT;
SAMPLING STUDIES;
|
|
EID: 0742289119
PISSN: 07438346
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.jp.7211011 Document Type: Letter |
|
Times cited : (8)
|
|
References (0)
|
